Cytokinetics
CYTK· Manufacturing· Fiscal year ends in December
Robert I. Blum is the CEO of Cytokinetics and was paid $11.9M in FY2025 (Dec).
Executives5
See all- 1Robert I. BlumPrincipal Executive OfficerFY2025
- 2Jeffrey HessekielExecutive Vice President, Chief Legal & Administrative OfficerFY2025
- 3Fady I. MalikExecutive Vice President, Research and DevelopmentFY2025
- 4Andrew M. CallosExecutive Vice President, Chief Commercial OfficerFY2025
- 5Sung H. LeePrincipal Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allCytokinetics paid its 5 named executives $30.0M in total in FY2025 (Dec). CEO Robert I. Blum was paid $11.9M of that.
| Name | |||
|---|---|---|---|
| Robert I. BlumPrincipal Executive Officer | Not disclosed | ||
| Jeffrey HessekielExecutive Vice President, Chief Legal & Administrative Officer | Not disclosed | Not disclosed | |
| Fady I. MalikExecutive Vice President, Research and Development | |||
| Andrew M. CallosExecutive Vice President, Chief Commercial Officer | |||
| Sung H. LeePrincipal Financial Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers21
See allThe FY2025 (Dec) proxy of Cytokinetics names 21 peer companies for pay. Among Cytokinetics and these peers, CEO pay was 6th highest of 9 and total shareholder return was 3rd highest of 9.
6th highest of 9in Cytokinetics and its pay peers, FY2025 (Dec) by CEO pay:
3rd highest of 9in Cytokinetics and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Edward M. Kaye, M.D.Director · 9 yr on the boardIndependentAudit, Compensation and Talent, Science and Technology—Paid as an executive
- Nancy J. WysenskiDirector · 5 yr on the boardIndependentCompensation and Talent (Chair), Compliance—Paid as an executive
- Robert A. HarringtonDirector · 3 yr on the boardIndependentNominating and Governance, Science and Technology—Paid as an executive
- James M. DalyDirector · 0 yr on the boardIndependentCompliance—Paid as an executive
The board of the latest proxy (FY2025).
Shared directors
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 17, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 10, 2025 | FY2024 |
| Annual report | 10-K | Feb 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 8, 2024 | FY2023 |
| Annual report | 10-K | Feb 28, 2024 | FY2023 |
